Actemra 160mg, a drug known scientifically as tocilizumab, functions as a potent biologic agent primarily utilized for the treatment of rheumatoid arthritis. This powerful compound acts by interfering with the activity of interleukin-6 (IL-6), a communication protein vital in the inflammatory process. Additionally, Actemra exhibits promise in the